COSMOS Pharmaceutical Corporation (TYO: 3349)
Japan
· Delayed Price · Currency is JPY 7,256.00
+54.00 (0.75%)
Sep 9, 2024, 3:15 PM JST
COSMOS Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 6, 2024 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2019 - 2015 |
| Market Capitalization | 575,093 | 502,890 | 525,081 | 483,107 | 603,094 | 612,599 | Upgrade
|
| Market Cap Growth | -4.23% | -4.23% | 8.69% | -19.90% | -1.55% | 80.30% | Upgrade
|
| Enterprise Value | 556,855 | 495,143 | 507,058 | 456,292 | 562,389 | 598,485 | Upgrade
|
| Last Close Price | 7256.00 | 6345.00 | 6573.53 | 6004.52 | 7454.28 | 7539.17 | Upgrade
|
| PE Ratio | 11.76 | 10.28 | 21.88 | 20.54 | 21.74 | 27.86 | Upgrade
|
| PS Ratio | 0.30 | 0.52 | 0.63 | 0.64 | 0.83 | 0.90 | Upgrade
|
| PB Ratio | 2.48 | 2.17 | 2.49 | 2.54 | 3.54 | 4.21 | Upgrade
|
| P/FCF Ratio | -791.95 | -791.95 | 67.34 | -42.74 | 333.02 | 15.50 | Upgrade
|
| P/OCF Ratio | 9.11 | 9.11 | 9.65 | 15.01 | 21.64 | 9.36 | Upgrade
|
| EV/Sales Ratio | 0.58 | 0.51 | 0.61 | 0.60 | 0.77 | 0.87 | Upgrade
|
| EV/EBITDA Ratio | 10.83 | 9.63 | 10.68 | 10.16 | 11.98 | 14.03 | Upgrade
|
| EV/EBIT Ratio | 17.68 | 15.72 | 16.83 | 15.31 | 16.97 | 20.57 | Upgrade
|
| EV/FCF Ratio | -876.94 | -779.75 | 65.02 | -40.37 | 310.54 | 15.15 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.15 | 0.09 | 0.05 | 0.06 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.66 | 0.66 | 0.38 | 0.21 | 0.22 | 0.28 | Upgrade
|
| Debt / FCF Ratio | -53.64 | -53.64 | 2.33 | -0.83 | 5.77 | 0.31 | Upgrade
|
| Asset Turnover | 2.15 | 2.15 | 2.11 | 2.14 | 2.20 | 2.30 | Upgrade
|
| Inventory Turnover | 9.49 | 9.49 | 9.16 | 9.52 | 10.19 | 10.28 | Upgrade
|
| Quick Ratio | 0.30 | 0.30 | 0.29 | 0.28 | 0.39 | 0.36 | Upgrade
|
| Current Ratio | 0.72 | 0.72 | 0.71 | 0.71 | 0.78 | 0.70 | Upgrade
|
| Return on Equity (ROE) | 11.05% | 11.05% | 11.85% | 12.83% | 17.17% | 15.76% | Upgrade
|
| Return on Assets (ROA) | 4.39% | 4.39% | 4.80% | 5.29% | 6.26% | 6.12% | Upgrade
|
| Return on Capital (ROIC) | 7.96% | 7.96% | 8.77% | 9.78% | 12.23% | 12.21% | Upgrade
|
| Earnings Yield | 8.51% | 4.86% | 4.53% | 4.79% | 4.50% | 3.50% | Upgrade
|
| FCF Yield | -0.11% | -0.13% | 1.49% | -2.34% | 0.30% | 6.45% | Upgrade
|
| Dividend Yield | 0.45% | - | 0.76% | 0.67% | 0.47% | 0.36% | Upgrade
|
| Payout Ratio | 19.05% | 19.05% | 13.72% | 14.10% | 8.38% | 9.69% | Upgrade
|
| Buyback Yield / Dilution | 49.97% | 49.97% | 0.00% | 0.00% | 0.00% | - | Upgrade
|
| Total Shareholder Return | 50.42% | 49.97% | 0.76% | 0.67% | 0.47% | 0.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.